FCGR3A and neoplasm: Similarly, trispecific killer engagers (TriKE) have been developed that consist of two scFv fragments connected by an IL-15 domain, enhancing NK cell-mediated anti-tumor efficacy by engaging CD16 on the NK cells and an antigen on the tumor cells.